Harmony Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.75M Buy
22,863
+13,094
+134% +$2.82M 1.54% 13
2026
Q1
$2.12M Buy
9,769
+2
+0% +$444 0.65% 43
2025
Q4
$2.23M Sell
9,767
-165
-2% -$37.6K 0.75% 35
2025
Q3
$2.3M Buy
9,932
+1
+0% +$204 0.79% 28
2025
Q2
$1.84M Sell
9,931
-136
-1% -$25.3K 0.69% 35
2025
Q1
$2.11M Sell
10,067
-398
-4% -$77.4K 0.89% 31
2024
Q4
$1.86M Sell
10,465
-375
-3% -$68.9K 0.74% 38
2024
Q3
$2.14M Sell
10,840
-96
-0.9% -$17.9K 0.79% 38
2024
Q2
$1.88M Sell
10,936
-6,569
-38% -$1.09M 0.79% 34
2024
Q1
$3.19M Sell
17,505
-4,204
-19% -$725K 1.31% 24
2023
Q4
$3.36M Buy
+21,709
New +$3.16M 1.42% 18

Other funds holding ABBV

Harmony Asset Management's ABBV Position: Q2 2026 in Review

Harmony Asset Management increased its AbbVie (ABBV) stake by 134% in Q2 2026, buying an estimated $2.82M and bringing the position to 22,863 shares worth $5.75M. The position accounts for 1.54% of the portfolio, ranked #13.

Harmony Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harmony Asset Management held 22,863 shares of AbbVie worth $5.75M as of Q2 2026.
  • Harmony Asset Management bought 13,094 AbbVie shares in Q2 2026, an estimated $2.82M.
  • AbbVie made up 1.54% of Harmony Asset Management's portfolio in Q2 2026, its #13 holding.
  • Harmony Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.